Site Map

Updated on 09.26.2006

Research

Advocacy & Action Alerts

Editorial Opinion

Research

2005/TreatmentChoicesForSchizophrenia.htm

Research Studies at Stanford

Having a Confidant May Ward Off Kids' Depression

Personality disorders improve naturally

Growth of Mental Health Services in State Adult Correctional Facilities, 1988 to 2000

2003 Census Data for Persons with Disabilities 9/04

Residential Facilities as the New Scenario of Long-Term Psychiatric Care

Treatment Of People With Mental Illness: A Decade-Long Perspective

Studies on Outcomes in the United States

Study Examines Use of Acupuncture to Aid Those w/ Bipolar Disorders

Integrative Medicine is the Wave of the Future

New Research on Treating Voices

Evidence of Neuroleptic Drug-Induced Brain Damage in Patients: A partial, Annotated Bibliography

SSRIs During Pregnancy May Cause Neurologic Symptoms in Newborns

HHS Study Finds Better Results in Self-Directed Care

Brain Imaging May Detect Schizophrenia in Early Stages

Patch Raises New Hope for Beating Depression

Stem Cells and Spinal Cord Injury

At NIMH, Outgrowing Jung Ideas

Dosing Regimens of Olanzapine and Risperidone

Research on the Drug Treatment of Schizophrenia: A Critical Appraisal and Implications for Social Work Education

2002/SocialWork_files/filelist.xml

Adherence Issues and Solutions with Antipsychotic Therapy

Increased Risk of Suicide From Psychotropic Drugs

Psychotic Illness Behind Few Violent Acts: Report

New Drugs for Children in the Pipeline

RU-486 Used to Treat Depression

Medications That Psychologists Would Like to Prescribe

New Treatment for Depression

2002/LeskellGammaKnife_files/filelist.xml

Against Depression, A Sugar Pill is Hard to Beat

	McMAN'S DEPRESSION AND BIPOLAR WEEKLY April 17, 2002
	McMAN'S DEPRESSION AND BIPOLAR WEEKLY May 1, 2002

Capacity to Provide Informed Consent to Psychiatric Trials

Creativity and Mental Illness

The Emperor's New Drugs

	Antipsychotics & Diabetes
	Atypical Neuroleptic Malignant Syndrome Associated With Olanzapine
	DO ANTIPSYCHOTIC DRUGS CHANGE BRAIN STRUCTURE?
	SSRI's: Effexor - Severe discontinuation symptoms can occur after missing a single dose
	Geodon
	Olanzapine
	Vaccines for Addiction

HMOs Losing Mental Health Appeals

Implants May Stabilize Schizophrenia Patients for a Year

Rabbit Syndrome Secondary to Risperidone

Researchers warn overmedication possible after finding medications linger in brain

Weight Gain Common Cause of Medication Discontinuation

Last Updated on 05/11/2008 webmaster@namiscc.org

Opinions expressed in this web site do not necessarily reflect the views of NAMI Santa Cruz County, NAMI California or any affiliated organizations. We attempt to present a balanced perspective on issues by presenting multiple viewpoints.

Copyright 2005 National Alliance for the Mentally Ill Santa Cruz County, All Rights Reserved.

FAIR USE NOTICE: This may contain copyrighted (�) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available to advance understanding of ecological, political, human rights, economic, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml If you wish to use copyrighted material for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.